Oncology Learning Network

Round 3: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma 30.01.2019 12:57 ↓

Round 3: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global

Round 2: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma 23.01.2019 22:56 ↓

Round 2: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global

CLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World Registry 22.01.2019 2:47 ↓

CLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World Registry by HMP Global

Gemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AML 21.12.2018 8:47 ↓

Gemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AML by HMP Global

Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML 20.12.2018 6:41 ↓

Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML by HMP Global

Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML 20.12.2018 4:45 ↓

Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML by HMP Global

The Use of CAR-T Therapy for B-Cell Lymphomas Outside of Clinical Trials 19.12.2018 6:57 ↓

The Use of CAR-T Therapy for B-Cell Lymphomas Outside of Clinical Trials by HMP Global

Round 1: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma 19.12.2018 20:07 ↓

Round 1: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global

Introduction: The Use of Adjuvant/ Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma 04.12.2018 1:17 ↓

Introduction: The Use of Adjuvant/ Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma by HMP Global

Quadruplet Therapy Yields Promising Results in Newly Diagnosed MM 30.11.2018 4:06 ↓

Quadruplet Therapy Yields Promising Results in Newly Diagnosed MM by HMP Global

Penn Medicine Looks to Improve Outcomes For Solid Tumors With CAR-T 14.11.2018 22:08 ↓

Penn Medicine Looks to Improve Outcomes For Solid Tumors With CAR-T by HMP Global

Navigating the Treatment Landscape for Multiple Myeloma - Callander 08.11.2018 21:28 ↓

Navigating the Treatment Landscape for Multiple Myeloma - Callander by HMP Global

Cost of Cancer Care in the Outpatient vs Community Oncology Setting - Lucio Gordon 08.11.2018 11:50 ↓

Cost of Cancer Care in the Outpatient vs Community Oncology Setting - Lucio Gordon by HMP Global

The Future of CML Treatment: An Interview With Gabriela Hobbs, MD - Part 3 08.11.2018 2:19 ↓

The Future of CML Treatment: An Interview With Gabriela Hobbs, MD - Part 3 by HMP Global

Jonathan Friedberg, MD, Discusses Burkitt Lymphoma 24.10.2018 1:01 ↓

Jonathan Friedberg, MD, Discusses Burkitt Lymphoma by HMP Global

Jonathan Friedberg, MD, Discusses The Future of Treatment for Aggressive Lymphomas - Part III 24.10.2018 1:56 ↓

Jonathan Friedberg, MD, Discusses The Future of Treatment for Aggressive Lymphomas - Part III by HMP Global

John Leonard, MD, Discusses the Evolving Treatment Landscape for Mantle Cell Lymphoma - Part I 24.10.2018 2:15 ↓

John Leonard, MD, Discusses the Evolving Treatment Landscape for Mantle Cell Lymphoma - Part I by HMP Global

Salvage Therapies for CML: An Interview With Gabriela Hobbs, MD - Part II 23.10.2018 4:06 ↓

Salvage Therapies for CML: An Interview With Gabriela Hobbs, MD - Part II by HMP Global

Jonathan Friedberg, MD - Treatment for Aggressive Lymphoma and Clinical Implications - Part II 23.10.2018 1:51 ↓

Jonathan Friedberg, MD - Treatment for Aggressive Lymphoma and Clinical Implications - Part II by HMP Global

John Leonard, MD - Future Outlook of Mantle Cell Lymphoma Treatment - Part III 23.10.2018 1:36 ↓

John Leonard, MD - Future Outlook of Mantle Cell Lymphoma Treatment - Part III by HMP Global

John Leonard, MD - Mantle Cell Lymphoma And Indolent Mantle Cell Lymphoma - Part II 23.10.2018 2:56 ↓

John Leonard, MD - Mantle Cell Lymphoma And Indolent Mantle Cell Lymphoma - Part II by HMP Global

John Leonard, MD - FL And Hematology Drugs In The Pipeline - Part IV 23.10.2018 2:33 ↓

John Leonard, MD - FL And Hematology Drugs In The Pipeline - Part IV by HMP Global

John Leonard, MD - Future Landscape Of FL Therapy, And Managing Survivors Of FL - Part III 23.10.2018 3:19 ↓

John Leonard, MD - Future Landscape Of FL Therapy, And Managing Survivors Of FL - Part III by HMP Global

John Leonard, MD - The Evolving Treatment Landscape for Follicular Lymphoma - Part I 23.10.2018 2:16 ↓

John Leonard, MD - The Evolving Treatment Landscape for Follicular Lymphoma - Part I by HMP Global

Dr. Gail Roboz - Clinical Trials and the Future of Treatment in AML – Part III 23.10.2018 3:34 ↓

Dr. Gail Roboz - Clinical Trials and the Future of Treatment in AML – Part III by HMP Global